<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: The aim of the study was to evaluate immunohistochemical expression of PRL-3 protein <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> buds, invasion front, central region of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIAL/METHODS: The PRL-3 expression was analyzed in 103 colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> patients, using the immunohistochemical method with a monoclonal antibody 3B6 anti-PRL-3 (Attogen Biomedical Research, USA) </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Positive reaction for PRL-3 was observed in 36.9% of cases in the central region of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, in 64.3% in the invasion front, and in as many as 81.4% in buds (present in 70/103 cases), in 100% in <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> to local lymph nodes, in 100% in <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> to the liver and in 97.1% in <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> to the lungs </plain></SENT>
<SENT sid="3" pm="."><plain>The findings indicate that <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells obtain this protein already in the early stages of metastasizing </plain></SENT>
<SENT sid="4" pm="."><plain>PRL-3 is present not only in <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> to local lymph nodes but also to distant organs </plain></SENT>
<SENT sid="5" pm="."><plain>It is likely that PRL-3 protein takes part in the initiation of metastasizing of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>Also the presence of lymph and blood vessel invasion was found only to correlate with increased percentage of patients with strong PRL-3 expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> buds (p=0.046) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Our results may suggests the participation of PRL-3 protein as a marker of the presence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> to the lymph nodes and distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e>, which is independent of parameters such as gender and age of the patients, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> location, histological type and grade of histological <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> and stage of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
</text></document>